ZLY032, the first-in-class dual FFA1/PPARδ agonist, improves glucolipid metabolism and alleviates hepatic fibrosis
Li Zheng, Zongtao Zhou, Lijun Hu, Liming Deng, Qiang Ren, Luyong Zhang
Topics & Concepts
EndocrinologyInternal medicineLipid metabolismInsulin resistancePeroxisome proliferator-activated receptorAgonistInflammationChemistryTriglycerideMetabolismFatty acid metabolismReceptorPeroxisomeFatty liverBeta oxidationOxidative stressInsulinBiologyMedicineCholesterolDiseaseLiver Disease Diagnosis and TreatmentPancreatic function and diabetesPeroxisome Proliferator-Activated Receptors